USA flag logo/image

An Official Website of the United States Government

Pincer Assays for Detecting Early Hepatitis C

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
Program Year/Program:
2012 / SBIR
Agency Tracking Number:
HHS200201252857
Solicitation Year:
N/A
Solicitation Topic Code:
N/A
Solicitation Number:
N/A
Small Business Information
MEDIOMICS, LLC
815 WENNEKER DRIVE SAINT LOUIS, MO 63124-
View profile »
Woman-Owned: No
Minority-Owned: Yes
HUBZone-Owned: No
 
Phase 2
Fiscal Year: 2012
Title: Pincer Assays for Detecting Early Hepatitis C
Agency: HHS
Contract: 200-2012-52857
Award Amount: $737,952.00
 

Abstract:

Early diagnosis of the hepatitis C virus (HCV) infection is crucial for treatment and prevention. PCR screening and ELISA-based assay are currently used to detect viral RNA and HCV antibodies in patient blood samples. There are, however, no commercially available serological assays which can discriminate between acute and chronic HCV infection. In the phase I project, the company developed magnetic bead-based PINCER assay as well as homogeneous PINCER assays for quick detection of anti-HCV IgG and IgM. To continue this project, it is proposed to 1. Validate the magnetic beads-based PINCER assay with patient samples, 2. Develop homogeneous PINCER assays using a complete panel of HCV antigens and validate the assays with clinical samples and 3. Develop and validate PINCER assays for HCV core antigen. It is expected that after successfully implementing the phase II project, the company will provide a unique set of simple, robust and cost-effective screening tools for detection of anti-HCV antibody and antigens for diagnosis of acute and chronic HCV infection

Principal Investigator:

Ling Tian
TianL@Mediomics.com

Business Contact:

Ling Tian
TianL@Mediomics.com
Small Business Information at Submission:

Mediomics, LLC
St. Louis, MO 63110-

EIN/Tax ID: 431936667
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No